Over the past few weeks we’ve been working with Spartan Bioscience to help them get their fast, accurate and portable COVID-19 test into communities across the country. Their innovation and quick actions to respond to the global pandemic are something to be admired.
In Spartan’s press release, CEO Paul Lem, M.D remarks:
“We are grateful to the Government of Canada for working closely with us to expedite the review and approval process,” said Paul Lem, M.D., CEO of Spartan Bioscience. “We are ready to start shipping our portable COVID-19 test to the federal and provincial governments, and to make them widely available to Canadians. There is an urgent unmet need for rapid COVID-19 testing, and as a proudly Canadian company, we are excited that our technology will be an important part of fighting the COVID-19 pandemic in Canada.”
Scaling an organization is difficult at the best of times, and Spartan is proving to be a strong force as they scale at a sprint.
Their technology is currently in use by many expert organizations such as the Centers for Disease Control (CDC), the New York State Department of Health, and the Mayo Clinic.
Stratford would like to offer its congrats to CEO, Dr. Paul Lem and his team at Spartan Bioscience on their approval from Health Canada to get this technology into the hands of those that need it most.
About Spartan Bioscience
Spartan Bioscience is a Canadian biotechnology company, and a world leader in portable on-demand DNA testing. Spartan’s technology fully integrates DNA collection, extraction, and analysis, with an intuitive interface that is easy to operate. The Spartan Cube, the world’s smallest DNA analyzer, enables unprecedented speed, accuracy and convenience in applications such as infectious disease, precision medicine, and food and water safety testing.
Stratford has worked with Spartan Bioscience in the area of business operations and continues to grow the relationship.